KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Current Leases: 2019-2025

Historic Current Leases for Pacira BioSciences (PCRX) over the last 7 years, with Sep 2025 value amounting to $9.7 million.

  • Pacira BioSciences' Current Leases rose 6.06% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 6.06%. This contributed to the annual value of $8.9 million for FY2024, which is 0.98% up from last year.
  • Pacira BioSciences' Current Leases amounted to $9.7 million in Q3 2025, which was up 1.33% from $9.6 million recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Current Leases registered a high of $9.7 million during Q3 2025, and its lowest value of $5.5 million during Q1 2021.
  • Moreover, its 3-year median value for Current Leases was $9.0 million (2024), whereas its average is $9.1 million.
  • Its Current Leases has fluctuated over the past 5 years, first decreased by 25.93% in 2021, then surged by 45.70% in 2022.
  • Quarterly analysis of 5 years shows Pacira BioSciences' Current Leases stood at $7.9 million in 2021, then climbed by 15.59% to $9.1 million in 2022, then declined by 3.51% to $8.8 million in 2023, then grew by 0.98% to $8.9 million in 2024, then increased by 6.06% to $9.7 million in 2025.
  • Its Current Leases was $9.7 million in Q3 2025, compared to $9.6 million in Q2 2025 and $9.4 million in Q1 2025.